» Articles » PMID: 31080515

Quantifying Local Malignant Adaptation in Tissue-specific Evolutionary Trajectories by Harnessing Cancer's Repeatability at the Genetic Level

Overview
Journal Evol Appl
Specialty Biology
Date 2019 May 14
PMID 31080515
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer is a potentially lethal disease, in which patients with nearly identical genetic backgrounds can develop a similar pathology through distinct combinations of genetic alterations. We aimed to reconstruct the evolutionary process underlying tumour initiation, using the combination of convergence and discrepancies observed across 2,742 cancer genomes from nine tumour types. We developed a framework using the repeatability of cancer development to score the local malignant adaptation (LMA) of genetic clones, as their potential to malignantly progress and invade their environment of origin. Using this framework, we found that premalignant skin and colorectal lesions appeared specifically adapted to their local environment, yet insufficiently for full cancerous transformation. We found that metastatic clones were more adapted to the site of origin than to the invaded tissue, suggesting that genetics may be more important for local progression than for the invasion of distant organs. In addition, we used network analyses to investigate evolutionary properties at the system-level, highlighting that different dynamics of malignant progression can be modelled by such a framework in tumour-type-specific fashion. We find that occurrence-based methods can be used to specifically recapitulate the process of cancer initiation and progression, as well as to evaluate the adaptation of genetic clones to given environments. The repeatability observed in the evolution of most tumour types could therefore be harnessed to better predict the trajectories likely to be taken by tumours and preneoplastic lesions in the future.

Citing Articles

Assessing Cell Activities rather than Identities to Interpret Intra-Tumor Phenotypic Diversity and Its Dynamics.

Monteiro L, Da Silva L, Lipinski B, Fauvet F, Vigneron A, Puisieux A iScience. 2020; 23(5):101061.

PMID: 32361272 PMC: 7195534. DOI: 10.1016/j.isci.2020.101061.


Separating the Local and Malignant Dimensions of Cancer Adaptation.

Roche B, Martinez P Cancer Inform. 2019; 18:1176935119872954.

PMID: 31523129 PMC: 6728660. DOI: 10.1177/1176935119872954.


Quantifying local malignant adaptation in tissue-specific evolutionary trajectories by harnessing cancer's repeatability at the genetic level.

Tokutomi N, Moyret-Lalle C, Puisieux A, Sugano S, Martinez P Evol Appl. 2019; 12(5):1062-1075.

PMID: 31080515 PMC: 6503823. DOI: 10.1111/eva.12781.

References
1.
Yates L, Campbell P . Evolution of the cancer genome. Nat Rev Genet. 2012; 13(11):795-806. PMC: 3666082. DOI: 10.1038/nrg3317. View

2.
Robinson D, Wu Y, Lonigro R, Vats P, Cobain E, Everett J . Integrative clinical genomics of metastatic cancer. Nature. 2017; 548(7667):297-303. PMC: 5995337. DOI: 10.1038/nature23306. View

3.
McGranahan N, Favero F, de Bruin E, Birkbak N, Szallasi Z, Swanton C . Clonal status of actionable driver events and the timing of mutational processes in cancer evolution. Sci Transl Med. 2015; 7(283):283ra54. PMC: 4636056. DOI: 10.1126/scitranslmed.aaa1408. View

4.
Gerlinger M, Rowan A, Horswell S, Math M, Larkin J, Endesfelder D . Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012; 366(10):883-892. PMC: 4878653. DOI: 10.1056/NEJMoa1113205. View

5.
Ortmann C, Kent D, Nangalia J, Silber Y, Wedge D, Grinfeld J . Effect of mutation order on myeloproliferative neoplasms. N Engl J Med. 2015; 372(7):601-612. PMC: 4660033. DOI: 10.1056/NEJMoa1412098. View